Pamapimod-impurities | Pharmaffiliates

Pamapimod

Pamapimod was being developed for use in the treatment of rheumatoid arthritis. symptoms of rheumatoid arthritis and other autoimmune diseases. Reference standards of Pamapimod API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Pamapimod - API Standards 
    [catalogue_number] => PA 16 3180000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 406.39
    [form] => C19H20F2N4O4
    [cas] => 449811-01-2
    [pslug] => 449811-01-2-pamapimod-api-pa163180000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 16 3180000

Pamapimod - API Standards


  • Catalogue No.:PA 16 3180000

  • CAS :

    449811-01-2

  • Molecular Formula : C19H20F2N4O4

  • Molecular Weight : 406.39

stdClass Object
(
    [pname] => 3-[(Phenylmethyl)amino]pentanedioic acid dimethyl ester
    [catalogue_number] => PA 16 3181000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 265.31
    [form] => C14H19NO4
    [cas] => 109270-76-0
    [pslug] => 109270-76-0-3-phenylmethyl-amino-pentanedioic-acid-dimethyl-ester-pa163181000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 16 3181000

3-[(Phenylmethyl)amino]pentanedioic acid dimethyl ester


  • Catalogue No.:PA 16 3181000

  • CAS :

    109270-76-0

  • Molecular Formula : C14H19NO4

  • Molecular Weight : 265.31